National Research Corp (NASDAQ: NRC)

Sector: Healthcare Industry: Health Information Services CIK: 0000070487
Market Cap 525.67 Mn
P/B 8.17
P/E 14.11
P/S 3.94
ROIC (Qtr) 18.39
Div Yield % 1.77
Rev 1y % (Qtr) -3.38
Total Debt (Qtr) 80.04 Mn
Debt/Equity (Qtr) 5.59

About

National Research Corporation, commonly referred to as NRC Health, is a prominent player in the healthcare information and market research services industry. The company, headquartered in Lincoln, Nebraska, has built a reputation over four decades as a leading provider of patient experience solutions for healthcare providers and other healthcare organizations. NRC Health's primary business activities revolve around providing actionable information and analysis to healthcare organizations. These services span a range of mission-critical, constituent-related...

Read more

Price action

Investment thesis

Bull case

  • Operating cash flow of 25.65M provides strong 16.12x coverage of stock compensation 1.59M, indicating sustainable incentive practices.
  • Operating cash flow of 25.65M provides solid 0.67x coverage of current liabilities 38.57M, showing strong operational health.
  • Operating cash flow of 25.65M provides strong 5.22x coverage of tax liabilities 4.91M, showing excellent fiscal position.
  • Operating cash flow of 25.65M provides strong 3.67x coverage of operating expenses 7M, showing operational efficiency.
  • Operating cash flow of 25.65M exceeds receivables of 12.75M by 2.01x, demonstrating excellent collection efficiency.

Bear case

  • Operating cash flow of 25.65M barely covers its investment activities of (14.03M), with a coverage ratio of -1.83, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 25.65M provides thin coverage of dividend payments of (11.10M) with a -2.31 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Operating cash flow of 25.65M provides insufficient coverage of deferred revenue obligations of 17.81M, which is 1.44x, raising concerns about future service delivery capabilities.
  • Operating cash flow of 25.65M is outpaced by equity issuance of (27.44M) (-0.93 ratio), indicating concerning reliance on equity markets for funding operations.
  • Tangible assets of 67.24M provide limited backing for working capital of (18.16M), which is -3.70x, suggesting increased operational risk in market downturns.

Timing of Transfer of Good or Service Breakdown of Revenue (2024)

Geographical Breakdown of Revenue (2024)

Peer comparison

Companies in the Health Information Services
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TEM Tempus AI, Inc. 45.63 Bn -223.83 41.29 1.34 Bn
2 GEHC GE HealthCare Technologies Inc. 38.75 Bn 19.85 2.19 10.28 Bn
3 VEEV Veeva Systems Inc 37.30 Bn 43.36 12.11 0.09 Bn
4 DOCS Doximity, Inc. 7.81 Bn 30.87 12.57 0.01 Bn
5 BTSG BrightSpring Health Services, Inc. 7.70 Bn 59.42 0.62 2.70 Bn
6 HQY Healthequity, Inc. 7.32 Bn 38.14 5.67 1.03 Bn
7 WAY Waystar Holding Corp. 5.00 Bn 44.97 4.81 1.25 Bn
8 PRVA Privia Health Group, Inc. 2.79 Bn 153.67 1.37 0.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 3.94 2.77
EV to Cash from Ops. EV/CFO 13.18 -10.86
EV to Debt EV to Debt 6.69 161.93
EV to EBIT EV/EBIT 12.37 -106.48
EV to EBITDA EV/EBITDA 10.67 4.22
EV to Free Cash Flow [EV/FCF] EV/FCF 14.61 7.46
EV to Market Cap EV to Market Cap 1.02 -14.93
EV to Revenue EV/Rev 4.02 1.76
Price to Book Value [P/B] P/B 8.17 10.57
Price to Earnings [P/E] P/E 14.11 147.14
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 1.47 -8.65
Dividend Payout Ratio % Div Payout % (Qtr) 67.60 5.00
Dividend per Basic Share Div per Share (Qtr) 0.48 0.04
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 91.43 4.57
Interest Coverage Int. cover (Qtr) 6.69 -584.72
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 5.04 -24.09
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -35.89 172.48
Dividend Growth (1y) % Div 1y % (Qtr) 0.00 -1.05
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -33.01 -17.73
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -20.22 39.85
EBIT Growth (1y) % EBIT 1y % (Qtr) -26.31 -38.83
EBT Growth (1y) % EBT 1y % (Qtr) -33.53 -4.52
EPS Growth (1y) % EPS 1y % (Qtr) -37.17 2.60
FCF Growth (1y) % FCF 1y % (Qtr) -53.85 -48.57
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -1.66 5.49
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.02 0.66
Cash Payout Ratio Cash Payout (Qtr) 0.28 0.03
Cash Ratio Cash Ratio (Qtr) 0.06 1.87
Current Ratio Curr Ratio (Qtr) 0.53 3.27
Debt to Equity Ratio Debt/Equity (Qtr) 5.59 -0.43
Interest Cover Ratio Int Coverage (Qtr) 6.69 -584.72
Times Interest Earned Times Interest Earned (Qtr) 6.69 -584.72
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 24.90 -435.80
EBIT Margin % EBIT Margin % (Qtr) 19.82 -464.70
EBT Margin % EBT Margin % (Qtr) 16.86 -461.74
Gross Margin % Gross Margin % (Qtr) 62.10 44.03
Net Profit Margin % Net Margin % (Qtr) 11.80 -468.01